Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

POEMS Syndrome: an Enigma.

Current hematologic malignancy reports - 1 Apr 2017

Warsame Rahma, Yanamandra Uday, Kapoor Prashant

Abstract excerpt

POEMS syndrome is a paraneoplastic disorder secondary to an underlying plasma cell dyscrasia. By definition, all patients with POEMS syndrome must display polyneuropathy and monoclonal plasma cell disorder. In addition, at least one major criterion (Castleman's disease, sclerotic bone lesions, or vascular endothelial growth factor elevation) and one minor criterion (organomegaly, extravascular volume overload,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Combined Modality Therapy
Share to Diagnosis, Differential

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Prognosis

Share to Treatment Outcome

Source

Identifiers

PMID: 28299525
DOI: 10.1007/s11899-017-0367-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

POEMS Syndrome: an Enigma.PMID 28299525Read ↗

POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

POEMS syndrome: A multisystem clonal disorder.Semantic proximity Read ↗

Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemiaSemantic proximity Read ↗

Prodromal myeloproliferative neoplasms: the 2008 WHO classification.Semantic proximity Read ↗

Update from the latest WHO classification of MPNs: a user's manual.Semantic proximity Read ↗

New Facets of Hematolymphoid Eponymic DiseasesSemantic proximity Read ↗

Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives.Semantic proximity Read ↗

How I treat polycythemia veraSemantic proximity Read ↗

Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated Vasculopathy.Semantic proximity Read ↗

Myeloproliferative neoplasms in the young: unique disease patterns and therapeutic strategies.Semantic proximity Read ↗

Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.Semantic proximity Read ↗

Chronic myeloproliferative diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.